Skip to content

Effect of flumazenil on emergence agitation after orthognathic surgery

Effect of flumazenil on emergence agitation after orthognathic surgery: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0006209
Enrollment
102
Registered
2021-05-28
Start date
2021-05-28
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : At the end of the operation, the anesthetic agent is stopped and flumazenil 0.3mg is administered by IV along with a reversal agent.

Sponsors

Chung-Ang Univerisity Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 18-65 year-old patients undergoing orthognathic orthognathic surgery under general anesthesia

Exclusion criteria

Exclusion criteria: Pregnant women, under 18 years old, over 65 years old, weight 45 kg or less, 100 kg or more, ASA 3 or more, patients with brain or psychiatric disorders or taking related drugs, patients with severe cardiovascular, kidney, liver, or hematologic abnormalities

Design outcomes

Primary

MeasureTime frame
Frequency of emergence agitation during arousal (AFPS 3 points or higher)

Secondary

MeasureTime frame
Time to first reaction from arousal;extubation time;Duration of emerence agitation

Countries

Korea, Republic of

Contacts

Public ContactCHONGWHA BAEK

Chung-Ang Univerisity Hospital

nbjhwa@naver.com+82-2-6299-2579

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026